Ivan Grid on Clubhouse

Bio

Entrepreneur, visionary.
MedTech | CardioTech | BioTech | AI/ML | DeepTech

CEO and co-founder of Life Science Technologies. life-science.tech

Project CARDIO
Increasing life quality and longevity.
Second medical and third AI opinion on heart health.
Deep tech disruptive innovations.
Computational biotech and pharmtech are involved.

Committed to solve major cause of death worldwide.

Project CARDIO
We will bring a professional cardiology “clinic” in your home. In a very small box, super user friendly and together with remote personal cardiologist on a daily basis. It is for sure the best present for your parents! Family heart health in your smartphone. What matters the most.

Project CARDIO
AI cloud connected home use device and remote personal cardiologist for prevention and personalized treatment efficiency control of hypertension and some other cardiovascular diseases.
Monthly paid subscriptions:
1. Detection
2. Prevention
3. Treatment efficiency control

The dataset, which we able get using our solution at home in 40 seconds, nowdays can be obtained only in the clinic through 3 different examinations within 1 hour using professional equipment and highly qualified doctors.

On website life-science.tech you can see our medical grade and clinically approved device report sample. 19 cardiovascular indicators in 40 seconds measurement at home.
Working on adding another 10 medical and 11 wellness grade indicators. Total 40 indicators. OMG it is a game changer!

Scientists, cardiologists, engineers, business partners, fundraising consultants and deep tech investors are welcome.

life-science.tech
t.me/ivangrid
[email protected]
wechat: ivan_sh
+79192124042
Russia | China, Shanghai


World Health Organization
Hypertension key facts

Hypertension - or elevated blood pressure - is a serious medical condition that significantly increases the risks of heart, brain, kidney and other diseases.

An estimated 1.5 billion people worldwide have hypertension.

Hypertension is a major cause of premature death worldwide.

1 in 4 men and 1 in 5 women had hypertension.

Fewer than 1 in 5 people with hypertension have the problem under control.

One of the global targets is to reduce the prevalence of hypertension by 25% by 2025